| Valdez, Erin G |
Stanford University
United States |
Circadian regulation of cancer therapy-associated neuroinflammation |
1R21CA267135-01A1 |
PAR-20-292 (R21 Clinical Trial Optional) |
Marge Good, R.N., M.P.H., O.C.N. |
| Tighiouart, Mourad |
Cedars-Sinai Medical Center
United States |
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials |
5U01CA232859-05 |
|
Diane St Germain, R.N., M.S., C.R.N.P. |
| Temel, Jennifer Sue |
Massachusetts General Hospital
United States |
Randomized Trial of Stepped Palliative Care versus Early Integrated Palliative Care in Patients with Advanced Lung Cancer |
5R01CA215188-05 |
|
Diane St Germain, R.N., M.S., C.R.N.P. |
| Taratula, Oleh |
Oregon State University
United States |
Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia |
5R37CA234006-04 |
|
Alexis Bakos, Ph.D., M.P.H., R.N. |
| Tamrazi, Benita |
Children'S Hospital Of Los Angeles
United States |
Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors |
5R21CA262978-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Diane St Germain, R.N., M.S., C.R.N.P. |
| Suga, Jennifer Marie |
Kaiser Foundation Research Institute
United States |
Kaiser Permanente NCI National Community Oncology Research Program, NCORP |
5UG1CA189821-09 |
|
Worta McCaskill-Stevens, M.D., M.S. |
| Strati, Paolo |
University Of Tx Md Anderson Can Ctr
United States |
Targeting Myeloid Cells to Mitigate Immune Effector Cell-Associated Neurotoxicity Syndrome in Large B-cell Lymphoma |
1R21CA259694-01 |
|
Alexis Bakos, Ph.D., M.P.H., R.N. |
| Stover, Daniel G. |
Ohio State University
United States |
Video Intervention to Address Pre-Test Patient Education for Tumor Genomic Testing |
1R21CA259985-01 |
|
Alexis Bakos, Ph.D., M.P.H., R.N. |
| Steel, Jennifer L. |
University Of Pittsburgh At Pittsburgh
United States |
Palliative care intervention for socioeconomically disadvantaged cancer patients |
5R01CA196953-05 |
|
Diane St Germain, R.N., M.S., C.R.N.P. |
| Staff, Nathan P |
Mayo Clinic Rochester
United States |
Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity |
1R01CA275870-01 |
PAR-21-329 (R01 Clinical Trial Optional) |
Alexis Bakos, Ph.D., M.P.H., R.N. |